ROTA Council Members


Despite the fact that safe, effective vaccines exist that can prevent rotavirus, the disease continues to kill nearly half a million children each year and hospitalizes millions more. Rotavirus vaccines are the most powerful tool to protect children, yet families in many parts of the world do not have access to them.

The ROTA Council is working to change this by providing the scientific and technical evidence policymakers need to accelerate the introduction of rotavirus vaccines. The mission of the ROTA Council is to save lives and improve health by promoting the use of rotavirus vaccines as part of a comprehensive approach to addressing diarrheal disease. What makes the ROTA Council unique is its focus on providing evidence for decision making through credible scientific authorities.


Mathuram Santosham
Johns Hopkins Bloomberg School
of Public Health, USA
Ciro A. de Quadros (in memoriam)
Sabin Vaccine Institute, USA

Core Partners

Umesh Parashar
US Centers for Disease Control
and Prevention, USA
Deborah Atherly

Council Members

Jon Andrus
Sabin Vaccine Institute, USA
George Armah
University of Ghana, Ghana
Mamadou Ba
Albert Royer Children’s Hospital, Senegal
Julie Bines
University of Melbourne, Australia
Lulu Bravo
University of the Philippines, Philippines
Nigel Cunliffe
University of Liverpool, UK
Shams El Arifeen
ICDDR,B, Bangladesh
Carlo Giaquinto
University of Padova, Italy
Roger Glass
Fogarty International Center, USA
Zulkifli Ismail
KPJ Selangor Specialist Hospital, Malaysia
Gagandeep Kang
Christian Medical College, India
Li Li
Chinese Center for Disease Control and Prevention, China
Alexandre C. Linhares
Ministry of Health, Brazil
Erkin Musabaev
Institute of Virology, Uzbekistan
Tony Nelson
Chinese University of Hong Kong, Hong Kong
Kathleen M. Neuzil
University of Maryland, USA
Vesta Richardson
Ministry of Health, Mexico
Duncan Steele
Bill & Melinda Gates Foundation, USA
Oyewale Tomori
Redeemer’s University, Nigeria
K. Zaman
icddr,b, Bangladesh

The ROTA Council will:

  • Effectively communicate evidence to policymakers and other key decisions makers on the toll of rotavirus and the impact of vaccines
  • Work with regional and in-country champions who can help communicate about, and raise awareness of, the rotavirus disease burden and potential impact of vaccines in reducing that burden
  • Strengthen partnerships across the diarrheal disease community to build support for rotavirus vaccine introduction and ensure that vaccines are seen as part of a comprehensive approach to addressing all of diarrhea’s causes
  • Proactively engage media to encourage and inform coverage of the rotavirus burden and the potential of vaccines
  • Support decision making at the country, regional and global levels by providing evidence to accelerate the introduction of rotavirus vaccines